Influences of somatotropin on biomechanical properties of porcine skin

Laboratory Animal Science

Volumn 49, Issue 2, 1999, Pages 212-215

  Caperna, Thomas J ^a,c   Vossoughi, Jafar ^b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b UNIVERSITY OF THE DISTRICT OF COLUMBIA   (United States)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; RECOMBINANT GROWTH HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BODY GROWTH; COLLAGEN METABOLISM; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; SKIN; SWINE; TENSILE STRENGTH;

ANIMALS; BIOMECHANICS; COLLAGEN; GROWTH HORMONE; MALE; ORCHIECTOMY; SKIN; SKIN PHYSIOLOGY; SWINE; TENSILE STRENGTH;

EID: 0032947913     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bauman, D. E., and R. G. Vernon. 1993. Effects of exogenous bovine somatotropin on lactation. Ann. Rev. Nutr. 13:437-461.
2. Steele, N. C., R. G. Campbell, T. J. Caperna, et al. 1989. PST efficacy in North America: management variables and advantages, p. 51-63. In P. van der Wal, G. J. Nieuwhof, and R. D. Politiek (ed.), Biotechnology for control of growth and product quality in swine. Implications and acceptability. Pudoc, Wageningen, Netherlands.
3. Fowler, V. R., and E. Kanis. 1989. Use of recombinant porcine somatotropin (rPST) in Europe; research experience and perspectives, p. 65-72. In P. van der Wal, G. J. Nieuwhof, and R. D. Politiek (ed.), Biotechnology for control of growth and product quality in swine. Implications and acceptability. Pudoc, Wageningen, Netherlands.
4. Darendeliler, F., P. C. Hindmarsh, and C. G. D. Brook. 1990. Dose-response curves for treatment with biosynthetic human growth hormone. J. Endocrinol. 125:311-316.
5. Salomon, F., R. C. Cuneo, R. Hesp, et al. 1989. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N. Engl. J. Med. 321:1797-1803.
6. Rosén, T., G. Johannsson, J-O. Johansson, et al. 1995. Consequences of growth hormone deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. Horm. Res. 43:93-99.
7. Hirschfeld, S. 1996. Use of human recombinant growth hormone and human recombinant insulin-like growth factor-I in patients with human immunodeficiency virus infection. Horm. Res. 46:215-221.
8. Torrado, C., W. Bastian, K. E. Wisniewski, et al. 1991. Treatment of children with Down syndrome and growth retardation with recombinant human growth hormone. J. Pediatr. 119:478-483.
9. Nienhuis, H. E., C. Rongen-Westerlaken, J. M. Wit, et al. 1993. Results of long-term therapy with growth hormone in two dose regimens in Turner syndrome. Horm. Res. 39 (Suppl. 2):31-36.
10. Ziegler, T. R., L. S. Young, E. Ferrari-Baliviera, et al. 1990. Use of human growth hormone combined with nutritional support in a critical care unit. J. Parenteral Enterai Nutr. 14:574-581.
11. Gore, D. C., D. Honeycutt, F. Jahoor, et al. 1991. Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch. Surg. 126:38-43.
12. Wernerman, J. 1993. Effect of growth hormone on muscle and protein in critically ill patients. Acta Endocrinol. 128(Suppl. 2):19-22.
13. Mehls, O., B. Tönshoff, C. Tönshoff, et al. 1992. Therapeutic value of recombinant human growth hormone in children with chronic renal failure. Miner. Electrolyte Metab. 18:320-324.
14. Van Dop, C., P. A. Donohoue, G. H. Bock, et al. 1989. Enhanced growth with growth hormone therapy after renal transplantation. Pediatr. Nephrol. 3:468-469.
15. Mjaaland, M., K. Unneberg, R. Hotvedt, et al. 1991. Nitrogen retention caused by growth hormone in patients undergoing gastrointestinal surgery with epidural analgesia and parenteral nutrition. Eur. J. Surg. 157:21-27.
16. Northmore-Ball, M. D., M. R. Wood, and B. F. Meggitt. 1980. A biomechanical study of the effects of growth hormone in experimental fracture healing. J. Bone Joint Surg. 62B: 391-396.
17. Hollander, D. M., D. F. Devereux, B. J. Marafino, Jr., et al. 1984. Increased wound breaking strength in rats following treatment with synthetic human growth hormone. Surg. Forum. 35:612-614.
18. Jørgensen, P. H., and T. T. Andreassen. 1987. A dose-response study of the effects of biosynthetic human growth hormone on formation and strength of granulation tissue. Endocrinology 121:1637-1641.
19. Bak, B., P. H. Jørgensen, and T. T. Andreassen. 1990. Dose response of growth hormone on fracture healing in the rat. Acta Orthop. Scand. 61:54-57.
20. Steenfos, H. H., and J-O. Jansson. 1992. Growth hormone stimulates granulation tissue formation and insulin-like growth factor-I gene expression in wound chambers in the rat. J. Endocrinol. 132:293-298.
21. Mosekilde, L., and B. Bak. 1993. The effects of growth hormone on fracture healing in rats: a histological description. Bone 14:19-27.
22. Vossoughi, J., and T. J. Caperna. 1992. Effect of growth hormone on tensile strength of diaphragm, p. 176-177. Proceedings of the 10th Southern Biomedical Engineering Conference, Memphis, Tenn.
23. Vossoughi, J., and T. J. Caperna. 1992. Effect of growth hormone on tensile strength and thickness of bladder from pigs, p. 13-14. Proceedings from the 2nd NorthAmerican Congress on Biomechanics.
24. Brüel, A., and H. Oxlund. 1991. Biosynthetic growth hormone changes the collagen and elastin contents and biomechanical properties of the rat aorta. Acta Endocrinol. 125: 49-57.
25. Jørgensen, P. H., T. T. Andreassen, and K. D. Jørgensen. 1989. Growth hormone influences collagen deposition and mechanical strength of intact rat skin. Acta Endocrinol. 120:767-772.
26. Allen, D. B., A. Fogo, R. El-Hayek, et al. 1992. Effects of prolonged growth hormone administration in rats with chronic renal insufficiency. Pediatr. Res. 31:406-410.
27. Evock, C. M., T. D. Etherton, C. S. Chung, et al. 1988. Pituitary porcine growth hormone (pGH) and a recombinant pGH analog stimulate pig growth performance in a similar manner. J. Anim. Sci. 66:1928-1941.
28. Caperna, T. J., D. Gavelek, and J. Vossoughi. 1994. Somatotropin alters collagen metabolism in growing pigs. J. Nutr. 124:770-778.
29. Vossoughi, J. 1984. Thickness measurement for soft rubber. Exp. Techniq. 8:32-33.
30. Fung, Y. C. 1993. Biomechanics, mechanical properties of living tissues, 2nd ed. Springer-Verlag, New York.
31. Vaishnav, R. N., and J. Vossoughi. 1984. Incremental formulations in vascular mechanics. J. Biomech. Engineer. 106:105-111.
32. Reihsner, R., and E. J. Menzel. 1996. On the orthogonal anisotropy of human skin as a function of anatomical region. Connect. Tissue Res. 34:145-160.
33. Thacker, J. G., M. C. Stalnecker, P. E. Allaire, et al. 1977 Practical applications of skin biomechanics. Clin. Plastic Surg. 4:167-171.
34. Oxlund, H., and T. T. Andreassen. 1980. The roles of hyaluronic acid, collagen and elastin in the mechanical properties of connective tissues. J. Anat. 131:611-620.
35. Aer, J., J. Halme, K. I. Kivirikko, et al. 1968. Action of growth hormone on the metabolism of collagen in the rat. Biochem. Pharmacol. 17:1173-1180.
36. Oxlund, H., P. H. Jørgensen, G. Ørtoft, et al. 1991. Alterations in the cross-links of skin collagen of rats treated with biosynthetic growth hormone. Conn. Tissue Res. 26:65-75.
37. Meyer, W., R. Schwarz, and K. Neurand. 1978. The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig. Curr. Prob. Dermatol. 7: 39-52.
38. Rudman, D., A. G. Feller, L. Cohn, et al. 1991. Effects of human growth hormone on body composition in elderly men. Horm. Res. 36(Suppl. 1):73-81.